Avastin 100 mg/4 ml

Avastin 100 mg/4 ml is a medicine authorised by Swissmedic under authorisation number 56922. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 16 December 2004 and the authorisation is valid without a time limit. ATC code L01FG01 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 56922
  • ATC L01FG01
  • Biotechnological medicines
Authorisation data
Authorisation number56922
NameAvastin 100 mg/4 ml
Full nameAvastin 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderRoche Pharma (Schweiz) AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FG01
First authorisation16 December 2004
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Avastin 100 mg/4 ml, Konzentrat zur Herstellung einer InfusionslösungA16 December 2004
2Avastin 400 mg/16 ml, Konzentrat zur Herstellung einer InfusionslösungA16 December 2004

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01FG0107.16.1.A
31Durchstechflasche(n)L01FG0107.16.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Avastin 100 mg/4 ml authorised in Switzerland?

Yes. Avastin 100 mg/4 ml is authorised by Swissmedic under authorisation number 56922, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Avastin 100 mg/4 ml have?

Avastin 100 mg/4 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Avastin 100 mg/4 ml?

The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com